Medical Director, Study Responsibly Physician - Oncology Late Development

Johnson & Johnson Johnson & Johnson · Pharma · Spring House, PA +4

Medical Director for Oncology Late Development at Johnson & Johnson, responsible for the scientific and operational execution of clinical research studies. This role involves supporting the Clinical Leader, contributing to protocol development, leading medical reviews of study data, interpreting and reporting results, and liaising with investigators and opinion leaders. The position focuses on developing new oncology treatments and requires strong scientific knowledge in oncology clinical research and ethical standards.

What you'd actually do

  1. Leads the project scientists, ensuring appropriate training, mentoring, and supervision across the assigned study/studies within the clinical development program.
  2. Works closely with functional partners (Data Management, Biostatistics, Regulatory, GCO, QMMC, GMS) to ensure an integrated and strategic approach to flawless execution and systematic oversight of study protocol(s) in late development in close collaboration with key functional stakeholders.
  3. Provides support for clinical study/studies within a development program including:
  4. Working closely with clinical project scientists in collaboration with GCO and GMS to ensure comprehensive medical monitoring, thorough and timely responses to address site issues and eligibility questions, and detailed, real time review of serious adverse events and deaths.
  5. Working in partnership with clinical project scientists to ensure development of high quality study protocols including use of consistent processes/standards across studies.

Skills

Required

  • Medical knowledge in oncology
  • Clinical research study design and execution
  • Data interpretation and reporting
  • Regulatory submission experience
  • Leadership and mentoring
  • Collaboration with cross-functional teams
  • Communication with investigators and opinion leaders

Nice to have

  • Experience in late-stage oncology development
  • Familiarity with global clinical trial operations
  • Understanding of health authority requirements